Page last updated: 2024-09-04

pyroglutamylleucine and morphine

pyroglutamylleucine has been researched along with morphine in 1 studies

Compound Research Comparison

Studies
(pyroglutamylleucine)
Trials
(pyroglutamylleucine)
Recent Studies (post-2010)
(pyroglutamylleucine)
Studies
(morphine)
Trials
(morphine)
Recent Studies (post-2010) (morphine)
70644,2705,2008,695

Protein Interaction Comparison

ProteinTaxonomypyroglutamylleucine (IC50)morphine (IC50)
Delta-type opioid receptorMus musculus (house mouse)0.2939
Delta-type opioid receptorRattus norvegicus (Norway rat)0.2278
Kappa-type opioid receptorMus musculus (house mouse)0.0828
Mu-type opioid receptorRattus norvegicus (Norway rat)0.0385
Kappa-type opioid receptorRattus norvegicus (Norway rat)0.0545
Mu-type opioid receptorHomo sapiens (human)0.122
Delta-type opioid receptorHomo sapiens (human)0.1199
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.9308
Kappa-type opioid receptorHomo sapiens (human)0.655
Mu-type opioid receptorMus musculus (house mouse)0.3305
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.202
Beta-2 adrenergic receptorCavia porcellus (domestic guinea pig)0.25

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baláspiri, L; Kovács, GL; Szontágh, L; Telegdy, G1

Other Studies

1 other study(ies) available for pyroglutamylleucine and morphine

ArticleYear
Dipeptides delay the onset of morphine withdrawal in the mouse.
    Acta physiologica Hungarica, 1984, Volume: 63, Issue:1

    Topics: Analysis of Variance; Animals; Dipeptides; Humans; Male; Mice; Morphine; Morphine Dependence; Naloxone; Pyrrolidonecarboxylic Acid; Substance Withdrawal Syndrome

1984